Researchers at the University of California, San Diego School of Medicine and Moores Cancer Center have identified a new biomarker and therapeutic target for pancreatic cancer, an often-fatal disease for which there is currently no reliable method for early detection or therapeutic intervention. The paper was published in Cancer Research. Pancreatic ductal adenocarcinoma, or PDAC, is the fourth-leading cause of cancer-related death. Newly diagnosed patients have a median survival of less than one year, and a 5-year survival rate of only 3 to 5 percent...
Realtime Related Tweets
underworld awakening dog the bounty hunter tacoma narrows bridge weather nyc open marriage department of justice doj
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.